Skip to content
Governance Register

← US public companies

Exagen INC.

SEC CIK 1274737 · XGN · last insider filing 2026-06-22

Directors (from insider filings)

NameCapacity as filedFilings
Kahn Scott D Director filed 2024 - 2026
Mckhann Chas Director filed 2026 - 2026
Stokes Frank Director filed 2021 - 2026
Aballi John Director · President and CEO filed 2022 - 2026
Kim Paul Director filed 2023 - 2025
Nova Tina Susan Director · Executive Chairperson filed 2019 - 2025
Hooker Ana Director filed 2021 - 2025
Tullis James L L Director filed 2019 - 2023
Pallares Ebetuel Director filed 2019 - 2023
Birk Brian Director filed 2019 - 2023
Johnson Wendy S. Director filed 2020 - 2023
Rocca Fortunato R. Director · President and CEO filed 2019 - 2022
Robertson Bruce C Director filed 2019 - 2021
Elliott Jeffrey Thomas Director filed 2019 - 2020
Burrell Chet Director filed 2019 - 2020

Officers (from insider filings)

NameTitle as filedFilings
Black Jeffrey G. Chief Financial Officer filed 2024 - 2026
Adawi Kamal Chief Financial Officer filed 2019 - 2024
Hazeltine Mark Chief Operating Officer filed 2021 - 2023
Zack Debra Chief Medical Officer filed 2020 - 2022
Dervieux Thierry Chief Scientific Officer filed 2019 - 2019

About this record

From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.

Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.